These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2557386)

  • 1. Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.
    Revello MG; Percivalle E; Zavattoni M; Parea M; Grossi P; Gerna G
    J Med Virol; 1989 Oct; 29(2):88-93. PubMed ID: 2557386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.
    Gerna G; Revello MG; Percivalle E; Zavattoni M; Parea M; Battaglia M
    J Clin Microbiol; 1990 Dec; 28(12):2681-8. PubMed ID: 2177748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
    Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
    Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.
    Gerna G; Zipeto D; Parea M; Revello MG; Silini E; Percivalle E; Zavattoni M; Grossi P; Milanesi G
    J Infect Dis; 1991 Sep; 164(3):488-98. PubMed ID: 1651361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis.
    Pannuti CS; Kallás EG; Muccioli C; Roland RK; Ferreira EC; Bueno SM; Do Canto CL; Villas Boas LS; Belfort Júnior R
    Am J Ophthalmol; 1996 Dec; 122(6):847-52. PubMed ID: 8956639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.
    Gerna G; Revello MG; Percivalle E; Morini F
    J Clin Microbiol; 1992 May; 30(5):1232-7. PubMed ID: 1316367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia.
    Grazia Revello M; Zavattoni M; Percivalle E; Grossi P; Gerna G
    J Infect Dis; 1989 Jul; 160(1):159-60. PubMed ID: 2543708
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.
    Revello MG; Percivalle E; Arbustini E; Pardi R; Sozzani S; Gerna G
    J Clin Invest; 1998 Jun; 101(12):2686-92. PubMed ID: 9637702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
    Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
    Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.
    Grossi P; Minoli L; Percivalle E; Irish W; Vigano M; Gerna G
    Transplantation; 1995 Mar; 59(6):847-51. PubMed ID: 7701579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
    Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
    J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients.
    Revello MG; Percivalle E; Di Matteo A; Morini F; Gerna G
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():437-42. PubMed ID: 1311365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
    J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients.
    Gerna G; Percivalle E; Grazia Revello M; Morini F
    Clin Diagn Virol; 1993 Mar; 1(1):47-59. PubMed ID: 15566718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of human cytomegalovirus DNA detection in immunocompromised heart transplant patients.
    Wolff C; Skourtopoulos M; Hörnschemeyer D; Wolff D; Körner M; Huffert F; Körfer R; Kleesier K
    Transplantation; 1996 Mar; 61(5):750-7. PubMed ID: 8607179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.